Browsing by Subject "Anxiety"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
Item A Tutorial on Cognitive Diagnosis Modeling for Characterizing Mental Health Symptom Profiles Using Existing Item Responses(Springer Nature, 2022-02-04) Tan, Zhengqi; de la Torre, Jimmy; Ma, Wenchao; Huh, David; Larimer, Mary E.; Mun, Eun-YoungIn research applications, mental health problems such as alcohol-related problems and depression are commonly assessed and evaluated using scale scores or latent trait scores derived from factor analysis or item response theory models. This tutorial paper demonstrates the use of cognitive diagnosis models (CDMs) as an alternative approach to characterizing mental health problems of young adults when item-level data are available. Existing measurement approaches focus on estimating the general severity of a given mental health problem at the scale level as a unidimensional construct without accounting for other symptoms of related mental health problems. The prevailing approaches may ignore clinically meaningful presentations of related symptoms at the item level. The current study illustrates CDMs using item-level data from college students (40 items from 719 respondents; 34.6% men, 83.9% White, and 16.3% first-year students). Specifically, we evaluated the constellation of four postulated domains (i.e., alcohol-related problems, anxiety, hostility, and depression) as a set of attribute profiles using CDMs. After accounting for the impact of each attribute (i.e., postulated domain) on the estimates of attribute profiles, the results demonstrated that when items or attributes have limited information, CDMs can utilize item-level information in the associated attributes to generate potentially meaningful estimates and profiles, compared to analyzing each attribute independently. We introduce a novel visual inspection aid, the lens plot, for quantifying this gain. CDMs may be a useful analytical tool to capture respondents' risk and resilience for prevention research.Item Coronavirus disease 2019 pandemic associated with anxiety and depression among Non-Hispanic whites with chronic conditions in the US(Elsevier B.V., 2022-02-22) Wang, Hao; Paul, Jenny; Ye, Ivana; Blalock, Jake; Wiener, R. Constance; Ho, Amy F.; Alanis, Naomi; Sambamoorthi, UshaOBJECTIVES: During the coronavirus 2019 (COVID-19) pandemic, increased anxiety and depression were reported, with mixed findings among individuals of different races/ethnicities. This study examines whether anxiety and depression increased during the COVID-19 pandemic compared to the pre-COVD-19 period among different racial/ethnic groups in the US. METHODS: The Health Information National Trend Surveys 5 (HINTS 5) Cycle 4 data was analyzed. We used the time when the survey was administered as the pre-COVID-19 period (before March 11, 2020, weighted N = 77,501,549) and during the COVID-19 period (on and after March 11, 2020, weighted N = 37,222,019). The Patient Health Questionnaire (PHQ) was used to measure anxiety/depression and further compared before and during COVID-19. Separate multivariable logistic regression analyses were used to determine the association of the COVID-19 pandemic with anxiety/depression after adjusting for age, sex, insurance, income, and education. RESULT: A higher percentage of Non-Hispanic whites (NHW) with chronic conditions reported anxiety (24.3% vs. 11.5%, p = 0.0021) and depression (20.7% vs. 9.3%, p = 0.0034) during COVID-19 than pre-COVID-19. The adjusted odds ratio (AOR) of anxiety and depression for NHWs with chronic conditions during the COVID-19 pandemic was 2.02 (95% confidence interval of 1.10-3.73, p = 0.025) and 2.33 (1.17-4.65, p = 0.018) compared to NHWs who participated in the survey before the COVID-19. LIMITATIONS: Limited to the NHW US population. PHQ can only be used as the initial screening tool. CONCLUSION: The COVID-19 pandemic was associated with an increased prevalence of anxiety and depression among NHW adults with chronic conditions, but not among people of color.Item Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults(Frontiers Media S.A., 2021-11-05) Hall, James R.; Petersen, Melissa E.; Johnson, Leigh A.; O'Bryant, Sid E.Depression and related neurobehavioral symptoms are common features of Alzheimer's disease and other dementias. The presence of these potentially modifiable neurobehavioral symptoms in cognitively intact older adults may represent an early indication of pathophysiological processes in the brain. Tau pathology is a key feature of a number of dementias. A number of studies have found an association between tau and neurobehavioral symptoms. The current study investigated the relationship of a blood-based biomarker of tau and symptoms of depression, anxiety, worry, and sleep disturbances in 538 community based, cognitively normal older adults. Logistic regression revealed no significant relationship between plasma total tau and any measures of neurobehavioral symptoms. To assess the impact of level of tau on these relationships, participants were divided into those in the highest quintile of tau and those in the lower four quintiles. Regression analyses showed a significant relationship between level of plasma total tau and measures of depression, apathy, anxiety, worry and sleep. The presence of higher levels of plasma tau and elevated neurobehavioral symptoms may be an early indicator of cognitive decline and prodromal Alzheimer's disease. Longitudinal research is needed to evaluate the impact of these factors on the development of dementia and may suggest areas for early intervention.Item RELATIONSHIP BETWEEN WORRY AND DEPRESSION IN ELDERLY MEXICAN-AMERICANS(2014-03) Sosa, Horacio; Johnson, Leigh; Hall, James; Edwards, Melissa; O'Bryant, Sid E.Purpose (a): Research has found a strong correlation between worry and mental and physical health. Later stages of life particularly entail increased stress related to multiple health problems, financial matters, etc., which often are associated with increased worry, anxiety and/or depression. In addition, worry has been linked to cognitive decline in the elderly. Our research has demonstrated that specific symptoms of depression (called the DepE) are related to cognitive impairment and can be used to identify a subgroup of individuals at greater risk for developing Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD). The goal of this study was to examine the relationship between DepE and worry in an elderly Mexican-American population. Methods (b): Data was collected from 253 Mexican-Americans (198 women, 60 men) enrolled in the Health and Aging Brain Study among Latino Elders (HABLE), a recently developed community-based study of factors related to aging. The mean age of the sample was 60 years, and the average years of education were 8. Worry was assessed using the Penn State Worry Questionnaire, and DepE was calculated using items from GDS30. The sample was divided into two groups based on DepE scores (high- and low-risk). Independent sample t-test was used to analyze the data. Results (c): The independent sample t-test showed a significant difference between the two groups (t = -10.4, p <0.05). Individuals with higher DepE scores have significantly higher scores in the PSWQ (Mean [SD] = 54 [16]), than those with low DepE scores (32 [13]). PSWQ items endorsed by the high-risk group include high worry under pressure (57%), an inability to dismiss worry (53%), consciousness about generalized worry (52%), a general tendency to worry (48%), and an inability to control worry (47%). Conclusions (d): DepE has been validated in multiple independent cohorts. Higher scores on the DepE are related to poor cognition and diagnosis of Mild Cognitive Impairment and Alzheimer’s disease (4). The results of this study suggest individuals with higher DepE scores have significantly higher worry, almost indicative of Generalized Anxiety Disorder according the PSWQ interpretation. This is consistent with literature linking worry to cognitive decline.Item Risk of psychological ill health and methods of organisational downsizing: a cross-sectional survey in four European countries(BioMed Central Ltd., 2017-09-29) Andreeva, Elena; Brenner, M. Harvey; Theorell, Töres; Goldberg, MarcelThe manner in which organizational downsizing is implemented can make a substantial difference as to whether the exposed workers will suffer from psychological ill health. Surprisingly, little research has directly investigated this issue. We examined the likelihood of psychological ill health associated with strategic and reactive downsizing.|A cross-sectional survey included 1456 respondents from France, Sweden, Hungary and the United Kingdom: 681 employees in stable workplaces (reference group) and 775 workers from downsized companies. Reactive downsizing was exemplified by the exposures to compulsory redundancies of medium to large scale resulting in job loss or surviving a layoff while staying employed in downsized organizations. The workforce exposed to strategic downsizing was represented by surplus employees who were internally redeployed and supported through their career change process within a policy context of "no compulsory redundancy". Symptoms of anxiety, depression and emotional exhaustion were assessed in telephone interviews with brief subscales from Hospital Anxiety Scale (HADS-A), Hopkins Symptom Checklist (SCL-CD|We observed no increased risk of psychological ill health in the case of strategic downsizing. The number of significant associations with psychological ill health was the largest for the large-scale reactive downsizing: surviving a layoff was consistently associated with all three outcome measures; returning to work after the job loss experience was related to anxiety and depression, while persons still unemployed at interview had elevated odds of anxiety. After reactive medium-scale downsizing, unemployment at interview was the only exposure associated with anxiety and depression.|The manner in which organizational downsizing is implemented can be important for the psychological wellbeing of workers. If downsizing is unavoidable, it should be achieved strategically. Greater attention is needed to employment and health policies supporting the workers after reactive downsizing.Item The SPADE symptom cluster and physical disability in chronic low back pain patients(2019-12) Hendrix, Zachary N.; Cross, Deanna S.; Licciardone, John C.; Kearns, Cathleen; Mathew, Stephen O.Introduction: Chronic pain is a major healthcare issue. It is debilitating and often occurs simultaneously with other health issues (Murray et al., 2013; Shmagel et al., 2016). The SPADE symptom cluster (sleep disturbance, pain interference, anxiety, depression, and low energy/fatigue) is common in chronic low back pain (cLBP) patients and may interact with their disability (Alamam et al., 2019; Davis et al., 2016; Tavares et al., 2019). Methods: This cross-sectional study utilized data from the Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation (PRECISION). The PROMIS-29 v2.0 was used to assess SPADE symptoms, and the Roland-Morris Disability Questionnaire was used to measure disability. The Spearman-Rho correlation between each SPADE symptom and disability was calculated. The correlations were then tested for significant differences and ranked in order of strongest to weakest correlation. Lastly, groups were assigned based on the number of presenting symptoms and tested for between-groups differences in mean disability. Results: Each of the five SPADE symptoms and the composite SPADE score were all positively and significantly correlated with disability. Pain Interference was most strongly correlated with disability. SPADE comorbidity was related to disability. Conclusion: SPADE symptoms greatly increase disability in chronic low back pain patients.